Phathom Pharmaceuticals receives FDA approval for Voquenza to treat non-erosive GERD
This marks the third FDA approval for Voquenza, which is also approved for treating all severities of Erosive Esophagitis (EE), also referred to as Erosive GERD, and in combination with antibiotics for eradicating Helicobacter pylori (H. pylori) infection. …